These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 16945045

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial.
    McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM.
    JAMA; 2004 Jan 14; 291(2):216-21. PubMed ID: 14722148
    [Abstract] [Full Text] [Related]

  • 3. Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial.
    Shah SA, Sander S, Cios D, Lipeika J, Kluger J, White CM.
    Ann Pharmacother; 2007 Mar 14; 41(3):420-5. PubMed ID: 17341532
    [Abstract] [Full Text] [Related]

  • 4. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects.
    Min B, Cios D, Kluger J, White CM.
    Pharmacotherapy; 2005 Dec 14; 25(12):1719-24. PubMed ID: 16305290
    [Abstract] [Full Text] [Related]

  • 5. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure.
    Vukovich MD, Schoorman R, Heilman C, Jacob P, Benowitz NL.
    Clin Exp Pharmacol Physiol; 2005 Dec 14; 32(1-2):47-53. PubMed ID: 15730434
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R, Sukbuntherng J, Luo W, Chen D, Vu A, Tovera J, Cundy KC.
    Clin Ther; 2009 Aug 14; 31(8):1776-86. PubMed ID: 19808136
    [Abstract] [Full Text] [Related]

  • 7. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R, Rosillon D, Bridson WE, Meeus MA, Salas E, Stockis A.
    Clin Ther; 2008 Feb 14; 30(2):260-70. PubMed ID: 18343264
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.
    Wang Z, Grasela DM, Krishna G.
    Clin Ther; 2007 Jun 14; 29(6):1098-106. PubMed ID: 17692724
    [Abstract] [Full Text] [Related]

  • 10. The effect of an herbal supplement containing black tea and caffeine on metabolic parameters in humans.
    Roberts AT, de Jonge-Levitan L, Parker CC, Greenway F.
    Altern Med Rev; 2005 Dec 14; 10(4):321-5. PubMed ID: 16366740
    [Abstract] [Full Text] [Related]

  • 11. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC, Fiske K, Lyne A.
    Clin Ther; 2007 Sep 14; 29(9):1967-79. PubMed ID: 18035196
    [Abstract] [Full Text] [Related]

  • 12. Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
    Marbury TC, Jin B, Panebianco D, Murphy MG, Sun H, Evans JK, Han TH, Constanzer ML, Dru J, Shadle CR.
    Anesth Analg; 2009 Aug 14; 109(2):418-25. PubMed ID: 19608812
    [Abstract] [Full Text] [Related]

  • 13. Blood pressure and heart rate effects following a single dose of bitter orange.
    Bui LT, Nguyen DT, Ambrose PJ.
    Ann Pharmacother; 2006 Jan 14; 40(1):53-7. PubMed ID: 16317106
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stereoselective cardiotoxic effects of terodiline.
    Hartigan-Go K, Bateman DN, Daly AK, Thomas SH.
    Clin Pharmacol Ther; 1996 Jul 14; 60(1):89-98. PubMed ID: 8689817
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular effect of almotriptan in treated hypertensive patients.
    Fleishaker JC, McEnroe JD, Azie NE, Francom SF, Carel BJ.
    Clin Pharmacol Ther; 2002 Mar 14; 71(3):169-75. PubMed ID: 11907491
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study.
    Charbit B, Alvarez JC, Dasque E, Abe E, Démolis JL, Funck-Brentano C.
    Anesthesiology; 2008 Aug 14; 109(2):206-12. PubMed ID: 18648229
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.